XML 43 R35.htm IDEA: XBRL DOCUMENT v3.24.3
SCHEDULES OF CONCENTRATION OF RISK BY RISK FACTOR (Details) - USD ($)
6 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Sep. 30, 2023
Product Information [Line Items]      
Revenue $ 7,659,537 $ 8,923,224  
Accounts receivable net 726,383   $ 1,429,299
Cost of revenue 6,726,294 8,684,797  
Customer A [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Revenue $ 1,864,655 $ 2,099,354  
Concentration risk, percentage 22.20% 22.30%  
Customer B [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Revenue $ 1,434,490 $ 1,797,766  
Concentration risk, percentage 17.10% 19.10%  
Customer C [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Revenue $ 1,242,771 $ 1,252,095  
Concentration risk, percentage 14.80% 13.30%  
Customer [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Revenue $ 4,541,916 $ 5,149,215  
Concentration risk, percentage 54.20% 54.70%  
A Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 34.90%   29.80%
Accounts receivable net $ 259,406   $ 437,898
B Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 19.30%  
Accounts receivable net $ 143,392  
C Customer [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 0.10%   31.30%
Accounts receivable net $ 617   $ 459,954
Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 54.30%   61.10%
Accounts receivable net $ 403,415   $ 897,852
Panaicia Pty Ltd [Member] | Cost of Sales [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Cost of revenue $ 2,414,279 $ 3,004,054  
Concentration risk, percentage 35.90% 34.60%  
Panaicia Pty Ltd [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 33.50%  
Cost of revenue $ 261,770  
Supplier A [Member] | Cost of Sales [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Cost of revenue $ 1,047,585 $ 1,725,911  
Concentration risk, percentage 15.60% 19.90%  
Supplier A [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 30.70%   88.50%
Cost of revenue $ 240,468   $ 2,301,224
Supplier B [Member] | Cost of Sales [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Cost of revenue $ 804,452 $ 1,194,857  
Concentration risk, percentage 12.00% 13.80%  
Supplier B [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage   2.10%
Cost of revenue   $ 54,188
Supplier C [Member] | Cost of Sales [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Cost of revenue $ 1,127,423  
Concentration risk, percentage 13.00%  
Supplier C [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 2.40%   4.10%
Cost of revenue $ 19,089   $ 108,743
Supplier [Member] | Cost of Sales [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Cost of revenue $ 4,266,316 $ 7,052,245  
Concentration risk, percentage 63.50% 81.30%  
Supplier [Member] | Accounts Payable [Member] | Customer Concentration Risk [Member]      
Product Information [Line Items]      
Concentration risk, percentage 66.60%   94.70%
Cost of revenue $ 521,327   $ 2,464,155